Indian company to establish a pharmaceutical plant in Andijan

A company from India will create an enterprise for the production of pharmaceutical products in the territory of the “Andijan-farm” free economic zone (FEZ).

Cadila Pharmaceuticals plans to allocate $50 million over the next five years for the project, of which at least $10 million will be spent on the first stage in 2020-2021.

30 types of medicines and medical devices will be produced. They will be registered in an expedited manner without charging a certificate fee.

Manba: Kun.uz